Literature DB >> 24069571

Emergence of Burkholderia cepacia in Honolulu: a case of nursing home-acquired B. cepacia sepsis.

Charles Nc Hua1, Jinichi Tokeshi.   

Abstract

Burkholderia cepacia has rarely been reported in Honolulu. Its emergence as a nursing home-acquired pathogen with high mortality rate is concerning. This case report describes a local nursing home patient who was diagnosed with B. cepacia sepsis in 2012.

Entities:  

Keywords:  Burkholderia; Pseudomonas; cepacia; elderly; infection; local; nursing home; sepsis

Mesh：

Year:  2013        PMID： 24069571      PMCID： PMC3780462     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN： 2165-8242


  16 in total

1.  Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei.

Authors:  Sharon J Peacock; Grace Chieng; Allen C Cheng; David A B Dance; Premjit Amornchai; Gumphol Wongsuvan; Nittaya Teerawattanasook; Wirongrong Chierakul; Nicholas P J Day; Vanaporn Wuthiekanun
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients.

Authors:  T Mann; D Ben-David; A Zlotkin; D Shachar; N Keller; A Toren; A Nagler; G Smollan; A Barzilai; G Rahav
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

3.  In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.

Authors:  Elke Peeters; Hans J Nelis; Tom Coenye
Journal:  J Antimicrob Chemother       Date:  2009-07-23       Impact factor: 5.790

Review 4.  Classification and identification of the Burkholderia cepacia complex: Past, present and future.

Authors:  Peter Vandamme; Peter Dawyndt
Journal:  Syst Appl Microbiol       Date:  2011-01-22       Impact factor: 4.022

5.  Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.

Authors:  P C Hardy; G M Ederer; J M Matsen
Journal:  N Engl J Med       Date:  1970-01-01       Impact factor: 91.245

6.  Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit.

Authors:  Chun-Hsing Liao; Hou-Tai Chang; Chih-Cheng Lai; Yu-Tsung Huang; Meng-Shuian Hsu; Chia-Ying Liu; Chia-Jui Yang; Po-Ren Hsueh
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03-09       Impact factor: 2.803

7.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

8.  Draft genome sequence determination for cystic fibrosis and chronic granulomatous disease Burkholderia multivorans isolates.

Authors:  John J Varga; Liliana Losada; Adrian M Zelazny; Lauren Brinkac; Derek Harkins; Diana Radune; Jessica Hostetler; Elizabeth P Sampaio; Catherine M Ronning; William C Nierman; David E Greenberg; Steven M Holland; Joanna B Goldberg
Journal:  J Bacteriol       Date:  2012-11       Impact factor: 3.490

9.  Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study.

Authors:  Adam M Bressler; Keith S Kaye; John J LiPuma; Barbara D Alexander; Christopher M Moore; L Barth Reller; Christopher W Woods
Journal:  Infect Control Hosp Epidemiol       Date:  2007-06-29       Impact factor: 3.254

Review 10.  Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?

Authors:  A Holmes; J Govan; R Goldstein
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883
View more
  1 in total

1.  Burkholderia Sepsis in Children as a Hospital-Acquired Infection.

Authors:  Kyu Yeun Kim; Dongeun Yong; Kyungwon Lee; Ho Seong Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.